IP Library Patent Application 16707721
Patent Application
App. No. 16/707,721

FACILITATING SEXUALLY TRANSMITTED INFECTION SERVICES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/707,721
Abstract

Systems and methods to facilitate services related to sexually transmitted disease (STI) testing and therapy are described herein. The invention relates to secure systems, methods, and devices for receiving, generating and managing user health data, creating user-specific profiles, and controls to facilitate requisition and delivery of services and products related to diagnostic testing and therapy. User-specific devices may be used to facilitate STI services described herein and may be used to provide information to a user and to collect information about a user.

Claims (37)

1 . A system to facilitate services for sexually transmitted infections, the system comprising:

a computing device;

a user-specific device configured to receive a request from a user and wirelessly communicate with the computing device;

a server configured to communicate and exchange data with the computing device, the server comprising a processor coupled to a computer-readable memory containing instructions executable by the processor to cause the server to:

receive input from the computing device to generate a user profile;

associate the user profile with the user-specific device;

receive, from the user-specific device, a request for a sexually transmitted infection (STI) service;

authorize the request; and

process the request.

2 . The system of claim 1 , wherein the server authorizes the request by authenticating the user via an authentication process selected from the group consisting of: biometric identification, password validation, and multi-factor authentication.

3 . The system of claim 2 , wherein the server is further configured to receive a command for an STI service from the user, wherein a positive authentication of the user authorizes the command to be executed.

4 . The system of claim 3 , wherein the command is to order a STI diagnostic test or a therapy.

5 . The system of claim 1 , wherein the server is further configured to prompt the user to order an STI service or to comply with therapy protocol.

6 . The system of claim 5 , wherein the user-specific device is further configured to deliver the prompt to the user, and wherein the prompt is an audible or visual stimulus generated by the user-specific device.

7 . The system of claim 1 , wherein the request is initiated upon the user interacting with the user-specific device.

8 . The system of claim 7 , wherein the user-specific device comprises an interactive component selected from the group consisting of: a button, a switch, a touch-screen, and a biometric sensor.

9 . The system of claim 1 , wherein the server is further configured to identify a reoccurring STI service based on the user profile.

10 . The system claim 4 , wherein the server is further configured to receive and input results from the diagnostic test into the user profile.

11 . The system of claim 4 , wherein the therapy is an antiviral therapeutic.

12 . The system of claim 4 , wherein the order is a reoccurring order.

13 . The system of claim 4 , wherein the prompt is to remind the user to order an antiviral therapy.

14 . A computer implemented method, the method comprising:

receiving initial input from a user, wherein the input is used to generate a user profile;

identifying an STI diagnostic test for the user based on the user profile;

receiving a request from the user via a user specific device;

authenticating the request;

ordering the STI diagnostic test kit; and

providing the STI diagnostic test kit to the user, wherein the kit is provided to customer in an unlabeled package.

15 . The computer implemented method of claim 14 , wherein the STI diagnostic kit comprises a specimen collection device.

16 . A method of monitoring compliance with an antiviral therapy protocol, the method comprising:

receiving initial input from a user prescribed an antiviral therapy;

identifying a testing compliance schedule for the user; and

prompting the user to order a compliance test kit via a user-specific device based on the schedule.

17 . The method of claim 16 , further comprising receiving a request from the user-specific device, wherein the request is generated by the user interacting with the user-specific device.

18 . The method of claim 17 , further comprising authenticating the user, wherein authentication is selected from the group consisting of: biometric identification, password validation, and multi-factor authentication.

19 . The method of claim 18 , further comprising authorizing the request and ordering the test, wherein the user is authenticated.

20 . The method of claim 19 , further comprising re-ordering the therapy, wherein results from the test indicate compliance with the protocol.

Assignments (5)
SECURITY INTEREST Recorded Mar 25, 2025
From: BINX HEALTH LIMITED
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 070620/0287 →
RELEASE OF SECURITY INTEREST Recorded Jan 18, 2025
From: BX HEP AGGREGATOR, LLC,
To: BINX HEALTH LIMITED
Reel/Frame 069925/0466 →
ASSIGNMENT OF PATENT SECURITY AGREEMENT Recorded Oct 3, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: BX HEP AGGREGATOR, LLC
Reel/Frame 069107/0116 →
PATENT SECURITY AGREEMENT Recorded Apr 7, 2021
From: BINX HEALTH LIMITED
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 055859/0724 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2020
From: LUBER, JEFFREY
To: BINX HEALTH LIMITED
Reel/Frame 051862/0070 →